FOXO1 and breast cancer: The study has demonstrated the association of Cdc25A, a cell-cycle-activating phosphatase overexpressed in breast cancer, with poor prognosis, which enhances the stability of FOXO1, and thereby directly stimulates the transcription of MMP1 [145].